{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:46:40Z","timestamp":1792806400389,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s10072-013-1415-8","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T01:10:26Z","timestamp":1369098626000},"page":"67-70","source":"Crossref","is-referenced-by-count":70,"title":["Dopaminergic symptoms in migraine"],"prefix":"10.1007","volume":"34","author":[{"given":"Piero","family":"Barbanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Fofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Aurilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Egeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,22]]},"reference":[{"key":"1415_CR1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10194-005-0143-8","volume":"6","author":"JN Blau","year":"2005","unstructured":"Blau JN (2005) Feeling and seeing headaches. J Headache Pain 6:10\u201319","journal-title":"J Headache Pain"},{"key":"1415_CR2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1526-4610.1977.hed1703129.x","volume":"17","author":"F Sicuteri","year":"1977","unstructured":"Sicuteri F (1977) Dopamine the second putative protagonist in headache. Headache 17:129\u2013131","journal-title":"Headache"},{"issue":"1","key":"1415_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-2982.2004.00711.x","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","unstructured":"Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders. 2nd edn. Cephalalgia 24(1):1\u2013160","journal-title":"Cephalalgia"},{"key":"1415_CR4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00002826-199102000-00008","volume":"14","author":"O Blin","year":"1991","unstructured":"Blin O, Azulay JP, Masson G, Aubrespy G, Serratrice G (1991) Apomorphine-induced yawning in migraine patients: enhanced responsiveness. Clin Neuropharmacol 14:91\u201395","journal-title":"Clin Neuropharmacol"},{"key":"1415_CR5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1526-4610.1994.hed3409536.x","volume":"34","author":"E Bene Del","year":"1994","unstructured":"Del Bene E, Poggioni M, De Tommasi F (1994) Video assessment of yawning induced by sublingual apomorphine in migraine. Headache 34:536\u2013538","journal-title":"Headache"},{"key":"1415_CR6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00002826-199702000-00004","volume":"20","author":"R Cerbo","year":"1997","unstructured":"Cerbo R, Barbanti P, Buzzi MG, Fabbrini G, Brusa L, Roberti C et al (1997) Dopamine hypersensitivity in migraine: role of the apomorphine test. Clin Neuropharmacol 20:36\u201341","journal-title":"Clin Neuropharmacol"},{"key":"1415_CR7","first-page":"23","volume":"6","author":"G Bussone","year":"1986","unstructured":"Bussone G, Boiardi A, La Mantia L, Frediani F, Lamperti E, Peccarisi C et al (1986) Clinical usefulness of a dopaminergic agonist in headache diagnosis. Int J Clin Pharmacol Res 6:23\u201326","journal-title":"Int J Clin Pharmacol Res"},{"key":"1415_CR8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1526-4610.1980.hed2002099.x","volume":"20","author":"M Fanciullacci","year":"1980","unstructured":"Fanciullacci M, Michelacci S, Curradi C, Sicuteri F (1980) Hyperresponsiveness of migraine patients to the hypotensive action of bromocriptine. Headache 20:99\u2013102","journal-title":"Headache"},{"key":"1415_CR9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1468-2982.1990.1006317.x","volume":"10","author":"S Nagel-Leiby","year":"1990","unstructured":"Nagel-Leiby S, Welch KM, D\u2019Andrea G, Grunfeld S, Brown E (1990) Event-related slow potentials and associated catecholamine function in migraine. Cephalalgia 10:317\u2013329","journal-title":"Cephalalgia"},{"key":"1415_CR10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1468-2982.1996.1601056.x","volume":"16","author":"J Castillo","year":"1996","unstructured":"Castillo J, Martinez F, Suarez C, Naveiro J, Lema M, Noya M (1996) Cerebrospinal fluid tyrosine and 3,4-dihydroxyphenylacetic acid levels in migraine patients. Cephalalgia 16:56\u201361","journal-title":"Cephalalgia"},{"key":"1415_CR11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1526-4610.2009.01533.x","volume":"50","author":"HJ Gruber","year":"2010","unstructured":"Gruber HJ, Bernecker C, Pailer S, Lechner A, Horejsi R, M\u00f6ller R et al (2010) Increased dopamine is associated with the cGMP and homocysteine pathway in female migraineurs. Headache 50:109\u2013116","journal-title":"Headache"},{"key":"1415_CR12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1526-4610.2006.00407.x","volume":"46","author":"G D\u2019Andrea","year":"2006","unstructured":"D\u2019Andrea G, Granella F, Perini F, Farruggio A, Leone M, Bussone G (2006) Platelet levels of dopamine are increased in migraine and cluster headache. Headache 46:585\u2013591","journal-title":"Headache"},{"key":"1415_CR13","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1526-4610.2012.02168.x","volume":"52","author":"G D\u2019Andrea","year":"2012","unstructured":"D\u2019Andrea G, D\u2019Arrigo A, Dalle Caerbonare M, Leon A (2012) Pathogenesis of migraine: role of neuromodulators. Headache 52:1155\u20131163","journal-title":"Headache"},{"issue":"207","key":"1415_CR14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0304-3940(96)12491-5","volume":"29","author":"P Barbanti","year":"1996","unstructured":"Barbanti P, Bronzetti E, Ricci A, Cerbo R, Fabbrini G, Buzzi MG et al (1996) Increased density of dopamine D5 receptor in peripheral blood lymphocytes of migraineurs: a marker for migraine? Neurosci Lett 29(207):73\u201376","journal-title":"Neurosci Lett"},{"key":"1415_CR15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1468-2982.2000.00001.x","volume":"20","author":"P Barbanti","year":"2000","unstructured":"Barbanti P, Fabbrini G, Ricci A, Pascali MP, Bronzetti E, Amenta F et al (2000) Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes. Cephalalgia 20:15\u201319","journal-title":"Cephalalgia"},{"key":"1415_CR16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12017-012-8195-9","volume":"15","author":"J Ghosh","year":"2013","unstructured":"Ghosh J, Pradhan S, Mittal B (2013) Identification of a novel ANKK1 and other dopaminergic (DRD2 and DBH) gene variants in migraine susceptibility. Neuromolecular Med 15:61\u201373","journal-title":"Neuromolecular Med"},{"key":"1415_CR17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00439-009-0623-z","volume":"125","author":"U Todt","year":"2009","unstructured":"Todt U, Netzer C, Toliat M, Heinze A, Goebel I, N\u00fcrnberg P et al (2009) New genetic evidence for involvement of the dopamine system in migraine with aura. Hum Genet 125:265\u2013279","journal-title":"Hum Genet"},{"key":"1415_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF03401725","volume":"4","author":"SJ Peroutka","year":"1998","unstructured":"Peroutka SJ, Price SC, Wilhoit TL, Jones KW (1998) Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Mol Med 4:14\u201321","journal-title":"Mol Med"},{"key":"1415_CR19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10194-007-0388-5","volume":"8","author":"C Asuni","year":"2007","unstructured":"Asuni C, Cherchi A, Congiu D, Piccardi MP, Del Zompo M, Stochino ME (2007) Association study between clinical response to rizatriptan and some candidate genes. J Headache Pain 8:185\u2013189","journal-title":"J Headache Pain"},{"key":"1415_CR20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1043-6618(03)00213-5","volume":"48","author":"ME Stochino","year":"2003","unstructured":"Stochino ME, Asuni C, Congiu D, Del Zompo M, Severino G (2003) Association study between the phenotype migraine without aura-panic disorder and dopaminergic receptor genes. Pharmacol Res 48:531\u2013534","journal-title":"Pharmacol Res"},{"key":"1415_CR21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1212\/WNL.51.3.781","volume":"51","author":"M Zompo Del","year":"1998","unstructured":"Del Zompo M, Cherchi A, Palmas MA, Ponti M, Bocchetta A, Gessa GL, Piccardi MP (1998) Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 51:781\u2013786","journal-title":"Neurology"},{"key":"1415_CR22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1468-2982.2004.00689.x","volume":"24","author":"N Rebaudengo","year":"2004","unstructured":"Rebaudengo N, Rainero I, Parziale A, Rosina F, Pavanelli E, Rubino E et al (2004) Lack of interaction between a polymorphism in the dopamine D2 receptor gene and the clinical features of migraine. Cephalalgia 24:503\u2013507","journal-title":"Cephalalgia"},{"key":"1415_CR23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s100720300005","volume":"23","author":"M Mochi","year":"2003","unstructured":"Mochi M, Cevoli S, Cortelli P, Pierangeli G, Soriani S, Scapoli C, Montagna P (2003) A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes. Neurol Sci 23:301\u2013305","journal-title":"Neurol Sci"},{"key":"1415_CR24","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1468-1331.2006.01415.x","volume":"13","author":"S Cevoli","year":"2006","unstructured":"Cevoli S, Mochi M, Scapoli C, Marzocchi N, Pierangeli G, Pini LA et al (2006) Genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol 13:1009\u20131013","journal-title":"Eur J Neurol"},{"key":"1415_CR25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1468-2982.2002.00313.x","volume":"22","author":"P Barbanti","year":"2002","unstructured":"Barbanti P, Fabbrini G (2002) Migraine and the extrapyramidal system. Cephalalgia 22:2\u201311","journal-title":"Cephalalgia"},{"key":"1415_CR26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1212\/WNL.59.1.72","volume":"59","author":"Y Cao","year":"2002","unstructured":"Cao Y, Aurora SK, Nagesh V, Patel SC, Welch KM (2002) Functional MRI-BOLD of brainstem structures during visually triggered migraine. Neurology 59:72\u201378","journal-title":"Neurology"},{"key":"1415_CR27","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1468-2982.2000.00123.x","volume":"20","author":"P Barbanti","year":"2000","unstructured":"Barbanti P, Fabbrini G, Vanacore N, Rum A, Lenzi GL, Meco G, Cerbo R (2000) Dopamine and migraine: does Parkinson\u2019s disease modify migraine course? Cephalalgia 20:720\u2013723","journal-title":"Cephalalgia"},{"key":"1415_CR28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00002826-200401000-00009","volume":"27","author":"E Cubo","year":"2004","unstructured":"Cubo E, Kompoliti K, Leurgans SE, Raman R (2004) Dopaminergic hypersensitivity in patients with Parkinson disease and migraine. Clin Neuropharmacol 27:30\u201332","journal-title":"Clin Neuropharmacol"},{"key":"1415_CR29","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1124\/jpet.109.151951","volume":"331","author":"AR Charbit","year":"2009","unstructured":"Charbit AR, Akerman S, Goadsby PJ (2009) Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complex. J Pharmacol Exp Ther 331:752\u2013763","journal-title":"J Pharmacol Exp Ther"},{"key":"1415_CR30","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.pain.2011.07.002","volume":"152","author":"AR Charbit","year":"2011","unstructured":"Charbit AR, Akerman S, Goadsby PJ (2011) Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms. Pain 152:2365\u20132376","journal-title":"Pain"},{"key":"1415_CR31","first-page":"101","volume":"17","author":"M Lai","year":"1997","unstructured":"Lai M, Loi V, Pisano MR, Del Zompo M (1997) Therapy of migraine by modulating dopamine hypersensitivity: its effect on mood and pain. Int J Clin Pharmacol Res 17:101\u2013103","journal-title":"Int J Clin Pharmacol Res"},{"key":"1415_CR32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1526-4610.1978.hed1802075.x","volume":"18","author":"BW Somerville","year":"1978","unstructured":"Somerville BW, Herrmann WM (1978) Migraine prophylaxis with Lisuride hydrogen maleate\u2014a double blind study of Lisuride versus placebo. Headache 18:75\u201379","journal-title":"Headache"},{"key":"1415_CR33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1046\/j.1526-4610.1999.3906426.x","volume":"39","author":"G Bussone","year":"1999","unstructured":"Bussone G, Cerbo R, Martucci N, Micieli G, Zanferrari C, Grazzi L et al (1999) Alpha-dihydroergocryptine in the prophylaxis of migraine: a multicenter double-blind study versus flunarizine. Headache 39:426\u2013431","journal-title":"Headache"},{"key":"1415_CR34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1468-2982.1994.014003235.x","volume":"14","author":"C W\u00f6ber","year":"1994","unstructured":"W\u00f6ber C, Br\u00fccke T, W\u00f6ber-Bing\u00f6l C, Asenbaum S, Wessely P, Podreka I (1994) Dopamine D2 receptor blockade and antimigraine action of flunarizine. Cephalalgia 14:235\u2013240","journal-title":"Cephalalgia"},{"key":"1415_CR35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1468-2982.1999.1901027.x","volume":"19","author":"LM Cupini","year":"1999","unstructured":"Cupini LM, Troisi E, Placidi F, Diomedi M, Silvestrini M, Argiro G, Bernardi G (1999) Does the antimigraine action of flunarizine involve the dopaminergic system? A clinical-neuroendocrinological study. Cephalalgia 19:27\u201331","journal-title":"Cephalalgia"},{"key":"1415_CR36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1468-2982.1984.0402085.x","volume":"4","author":"J Waelkens","year":"1984","unstructured":"Waelkens J (1984) Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia 4:85\u201390","journal-title":"Cephalalgia"},{"key":"1415_CR37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11940-011-0150-9","volume":"14","author":"J Marmura","year":"2012","unstructured":"Marmura J (2012) Use of dopamine antagonists in treatment of migraine. Curr Treat Options Neurol 14:27\u201335","journal-title":"Curr Treat Options Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-013-1415-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-013-1415-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-013-1415-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T20:18:11Z","timestamp":1563049091000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-013-1415-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":37,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["1415"],"URL":"https:\/\/doi.org\/10.1007\/s10072-013-1415-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}